Folgen
Carlos Juan
Carlos Juan
Immunology associate professor (UIB), Microbiology Researcher Hospital Son Espases, Palma
Bestätigte E-Mail-Adresse bei uib.cat
Titel
Zitiert von
Zitiert von
Jahr
The increasing threat of Pseudomonas aeruginosa high-risk clones
A Oliver, X Mulet, C López-Causapé, C Juan
Drug Resistance Updates 21, 41-59, 2015
6282015
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver
PLoS pathogens 5 (3), e1000353, 2009
3212009
Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance
A Doménech-Sánchez, L Martínez-Martínez, S Hernández-Allés, ...
Antimicrobial agents and chemotherapy 47 (10), 3332-3335, 2003
272*2003
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals
O Gutiérrez, C Juan, E Cercenado, F Navarro, E Bouza, P Coll, JL Pérez, ...
Antimicrobial agents and chemotherapy 51 (12), 4329-4335, 2007
2652007
Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains
C Juan, MD Maciá, O Gutiérrez, C Vidal, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 49 (11), 4733-4738, 2005
2462005
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
2452012
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
2362014
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ...
Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011
2282011
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
2202016
Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD …
C Juan, B Moyá, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 50 (5), 1780-1787, 2006
2162006
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and …
J Oteo, K Diestra, C Juan, V Bautista, Â Novais, M Pérez-Vázquez, ...
International journal of antimicrobial agents 34 (2), 173-176, 2009
1962009
Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic …
A Oliver, BR Levin, C Juan, F Baquero, J Blázquez
Antimicrobial agents and chemotherapy 48 (11), 4226-4233, 2004
1792004
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
1762012
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
PA Fraile-Ribot, G Cabot, X Mulet, L Periañez, ML Martín-Pena, C Juan, ...
Journal of Antimicrobial Chemotherapy 73 (3), 658-663, 2018
1752018
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
C Juan, C Peña, A Oliver
The Journal of infectious diseases 215 (suppl_1), S44-S51, 2017
1552017
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
1432013
Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones
C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver
Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010
1342010
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 …
E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ...
Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009
1342009
Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after …
B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010
1282010
Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa
B Moya, C Juan, S Albertí, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 52 (10), 3694-3700, 2008
1272008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20